08:00 , Feb 13, 2012 |  BC Week In Review  |  Company News

AGI Therapeutics, Aravis Therapeutics deal

AGI said shareholders had tendered 54 million shares (80.2%) under Aravis' offer to acquire AGI for €10.7 million ($14 million). The offer remains open until Feb. 17 (see BioCentury, Jan. 16). AGI Therapeutics plc (ISE:A91;...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Company News

AGI Therapeutics, Aravis Therapeutics deal

Aravis began its tender offer to acquire AGI Therapeutics for €10.7 million ($13.6 million) in cash. AGI's board unanimously recommended that AGI shareholders accept the offer. Aravis said the acquisition will provide a management team...